Pharmacogenetics of Oxaliplatin as Adjuvant Treatment in Colon Carcinoma: Are Single Nucleotide Polymorphisms in GSTP1, ERCC1, and ERCC2 Good Predictive Markers?

Author： Sarasqueta Arantza Fariña   >  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.15, Iss.5, 2011-10, pp. : 277-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single Nucleotide Polymorphisms in Nucleotide Excision Repair Genes XPA, XPD, XPG and ERCC1 in Advanced Colorectal Cancer Patients Treated with First-Line Oxaliplatin/Fluoropyrimidine

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 364-370

Karger

Access to resources Recommend Favorite

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2720-2729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with Surgery and Adjuvant Cisplatin-Based Chemoradiation

By  

Oncology, Vol. 89, Iss. 4, 2015-06 ,pp. : 227-234

Karger

Access to resources Recommend Favorite

RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin

By  

Oncology Research and Treatment, Vol. 35, Iss. 11, 2012-10 ,pp. : 673-682

Karger

Access to resources Recommend Favorite

Impact of XRCC1, GSTP1, and GSTM1 Polymorphisms on the Survival of Ovarian Carcinoma Patients Treated with Chemotherapy

By  

Oncology Research and Treatment, Vol. 39, Iss. 7-8, 2016-06 ,pp. : 440-446

Karger

Access to resources Recommend Favorite